Diana is a senior leader with more than 38 years of field experience in U.S. FDA's Office of Regulatory Affairs (ORA). She previously served in two leadership positions in ORA as the New Jersey District Director and as the Office of Pharmaceutical Quality Operations Division I Director. In these roles, she provided executive leadership in directing and managing FDA pharmaceutical inspectional and compliance activities.
She has been recognized with numerous awards, including the U.S. FDA Commissioner's Special Citation and FDA's highest award, the Award of Merit.
Commenting on the appointment, Vinita Gupta, Chief Executive Officer and Nilesh Gupta, Managing Director, Lupin said, "Quality is one of the most critical pillars of our organization, and we are delighted to have a leader with Diana's experience and track record of excellence come on board.
We are confident that Diana's passion for quality and developing talent will make a significant difference in our efforts to achieve the highest standards of quality and compliance."
Lupin was trading at Rs745 apiece down by Rs13.5 or 1.78% on the BSE.
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.